About PharmaZell
PharmaZell, headquartered near Munich, Germany, is a materials and services supplier to the pharmaceutical industry with API production facilities in Germany, Denmark and India. The company was successfully spun out of Lubrizol in 2006 through a management buy-out together with the private equity firm Auctus (Munich, Germany).
On June 1, 2007, PharmaZell acquired a significant stake in GEA Pharmaceutical A/S (Copenhagen, Denmark) from Sandoz. GEA Pharmaceutical A/S specializes in the development of solid dosage forms and provides all services related to pharmaceutical development from analytical development to filling of pharmaceutical registration dossiers.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Employees: 501-1,000
- Industry : Pharma
Product portfolio of PharmaZell
Here you will find PharmaZell GmbH
Last viewed contents
List_of_lycaenid_genera:_C
Atheris_hispida
Intercell completed the acquisition of Cytos' antibody technology platform
Study finds fire stations contaminated with MRSA
List_of_gelechiid_genera:_L
List_of_gelechiid_genera:_C
Cepheid Expands Distribution in China
List_of_arctiid_genera:_X
List_of_arctiid_genera:_F
List_of_geometrid_genera:_B
